Simpson Thacher was recently awarded a 2014 Deal of the Year by the India Business Law Journal for our representation of KKR in connection with its approximately US$200 million acquisition of a minority stake in Gland Pharma Limited. The transaction marks KKR’s largest private equity investment in an Indian pharmaceutical company. Established in 1978 and based in Hyderabad, India, Gland Pharma was the first company in India to get US Food and Drug Administration (FDA) approval for pharmaceutical liquid injectable products in 2003. For more information about the winning transaction, click here.